Suppr超能文献

用于戒烟的醋酸银。

Silver acetate for smoking cessation.

作者信息

Lancaster Tim, Stead Lindsay F

机构信息

Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

出版信息

Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD000191. doi: 10.1002/14651858.CD000191.pub2.

Abstract

BACKGROUND

Silver acetate produces an unpleasant taste when combined with cigarettes, thereby producing an aversive stimulus. It has been marketed in various forms with the aim of extinguishing the urge to smoke, by pairing the urge with an unpleasant stimulus.

OBJECTIVES

The aim of this review was to determine the effectiveness of silver acetate products (gum, lozenge, spray) in promoting smoking cessation.

SEARCH METHODS

We searched the Cochrane Tobacco Addiction Group specialised trials register. Most recent search was in July 2012.

SELECTION CRITERIA

We included randomised trials of silver acetate for smoking cessation with reports of smoking status at least six months after the beginning of treatment.

DATA COLLECTION AND ANALYSIS

We extracted data in duplicate on the type of subjects, the dose and form of silver acetate, the outcome measures, method of randomisation, and completeness of follow-up.The main outcome measure was biochemically validated abstinence from smoking after at least six months follow-up in patients smoking at baseline. Subjects lost to follow-up were counted as continuing smokers. Where appropriate, we performed meta-analysis using a fixed effects model.

MAIN RESULTS

Two studies provided long-term follow-up data on patients randomised to silver acetate or placebo. In one of these studies, there was a third arm, randomised to 2mg nicotine gum. The pooled risk ratio for quitting for silver acetate vs placebo was 1.04 (95% confidence interval 0.69 to 1.57).

AUTHORS' CONCLUSIONS: Existing trials show little evidence for a specific effect of silver acetate in promoting smoking cessation. The confidence intervals for the ratio are quite wide. However, the upper limit of the confidence intervals for a positive effect equates to an absolute increase in the smoking cessation rate of about 4%. Any effect of this agent is therefore likely to be smaller than nicotine replacement therapy. The lack of effect of silver acetate may reflect poor compliance with a treatment whose rationale is to create an unpleasant stimulus.

摘要

背景

醋酸银与香烟混合时会产生令人不适的味道,从而产生厌恶刺激。它以多种形式销售,目的是通过将吸烟冲动与不愉快刺激配对来消除吸烟冲动。

目的

本综述的目的是确定醋酸银产品(口香糖、含片、喷雾剂)在促进戒烟方面的有效性。

检索方法

我们检索了Cochrane烟草成瘾小组专门的试验注册库。最近一次检索是在2012年7月。

选择标准

我们纳入了醋酸银用于戒烟的随机试验,这些试验报告了治疗开始后至少六个月的吸烟状况。

数据收集与分析

我们对受试者类型、醋酸银的剂量和形式、结局指标、随机化方法以及随访完整性进行了重复数据提取。主要结局指标是对基线时吸烟的患者进行至少六个月随访后经生化验证的戒烟情况。失访的受试者被视为持续吸烟者。在适当情况下,我们使用固定效应模型进行荟萃分析。

主要结果

两项研究提供了随机分配至醋酸银或安慰剂组患者的长期随访数据。在其中一项研究中,还有第三组被随机分配至2毫克尼古丁口香糖组。醋酸银组与安慰剂组戒烟的合并风险比为1.04(95%置信区间0.69至1.57)。

作者结论

现有试验几乎没有证据表明醋酸银在促进戒烟方面有特定效果。该比值的置信区间相当宽。然而,积极效果的置信区间上限相当于戒烟率绝对增加约4%。因此,该药物的任何效果可能都小于尼古丁替代疗法。醋酸银缺乏效果可能反映了对一种旨在产生不愉快刺激的治疗方法依从性较差。

相似文献

1
Silver acetate for smoking cessation.用于戒烟的醋酸银。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD000191. doi: 10.1002/14651858.CD000191.pub2.
2
Silver acetate for smoking cessation.
Cochrane Database Syst Rev. 2000(2):CD000191. doi: 10.1002/14651858.CD000191.
3
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2012 Nov 14;11:CD000146. doi: 10.1002/14651858.CD000146.pub4.
4
Interventions to reduce harm from continued tobacco use.减少持续吸烟危害的干预措施。
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
5
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2016 May 9;2016(5):CD006103. doi: 10.1002/14651858.CD006103.pub7.
6
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2000(3):CD000146. doi: 10.1002/14651858.CD000146.
7
Nicotine replacement therapy versus control for smoking cessation.尼古丁替代疗法与对照用于戒烟
Cochrane Database Syst Rev. 2018 May 31;5(5):CD000146. doi: 10.1002/14651858.CD000146.pub5.
8
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD000146. doi: 10.1002/14651858.CD000146.pub3.
9
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2002(4):CD000146. doi: 10.1002/14651858.CD000146.
10
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2010 Dec 8(12):CD006103. doi: 10.1002/14651858.CD006103.pub4.

引用本文的文献

4
Psychosocial interventions for supporting women to stop smoking in pregnancy.支持孕期女性戒烟的心理社会干预措施。
Cochrane Database Syst Rev. 2017 Feb 14;2(2):CD001055. doi: 10.1002/14651858.CD001055.pub5.
7
Psychosocial interventions for supporting women to stop smoking in pregnancy.支持孕期妇女戒烟的心理社会干预措施。
Cochrane Database Syst Rev. 2013 Oct 23;10(10):CD001055. doi: 10.1002/14651858.CD001055.pub4.

本文引用的文献

2
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD000146. doi: 10.1002/14651858.CD000146.pub3.
3
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2007 Jan 24(1):CD006103. doi: 10.1002/14651858.CD006103.pub2.
4
Silver acetate for smoking cessation.
Cochrane Database Syst Rev. 2000(2):CD000191. doi: 10.1002/14651858.CD000191.
6
Effects of a 2.5-mg silver acetate lozenge on initial and long-term smoking cessation.
Prev Med. 1996 Sep-Oct;25(5):537-46. doi: 10.1006/pmed.1996.0087.
7
Smoking deterrence using silver acetate.
Hosp Community Psychiatry. 1993 Feb;44(2):113-4, 118. doi: 10.1176/ps.44.2.113.
9
Silver acetate gum as a deterrent to smoking.
Chest. 1986 Jul;90(1):107-11. doi: 10.1378/chest.90.1.107.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验